Literature DB >> 22890077

Chronic restraint stress decreases glial fibrillary acidic protein and glutamate transporter in the periaqueductal gray matter.

H Imbe1, A Kimura, T Donishi, Y Kaneoke.   

Abstract

Stress affects brain activity and promotes long-term changes in multiple neural systems. Exposure to stressors causes substantial effects on the perception and response to pain. In several animal models, chronic stress produces lasting hyperalgesia. Postmortem studies of stress-related psychiatric disorders have demonstrated a decrease in the number of astrocytes and the level of glial fibrillary acidic protein (GFAP), a marker for astrocyte, in the cerebral cortex. Since astrocytes play vital roles in maintaining neuroplasticity via synapse maintenance and secretion of neurotrophins, impairment of astrocytes is thought to be involved in the neuropathology. In the present study we examined GFAP and excitatory amino acid transporter 2 (EAAT2) protein levels in the periaqueductal gray matter (PAG) after subacute and chronic restraint stresses to clarify changes in descending pain modulatory system in the rat with stress-induced hyperalgesia. Chronic restraint stress (6h/day for 3 weeks), but not subacute restraint stress (6h/day for 3 days), caused a marked mechanical hypersensitivity and aggressive behavior. The chronic restraint stress induced a significant decrease of GFAP protein level in the PAG (32.0 ± 8.9% vs. control group, p<0.05). In immunohistochemical analysis the remarkable decrease of GFAP was observed in the ventrolateral PAG. The EAAT2 protein level in the 3 weeks stress group (79.6 ± 6.8%) was significantly lower compared to that in the control group (100.0 ± 6.1%, p<0.05). In contrast there was no significant difference in the GFAP and EAAT2 protein levels between the control and 3 days stress groups These findings suggest a dysfunction of the PAG that plays pivotal roles in the organization of strategies for coping with stressors and in pain modulation after chronic restraint stress.
Copyright © 2012 IBRO. Published by Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22890077     DOI: 10.1016/j.neuroscience.2012.08.007

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  17 in total

1.  Impairment of adenylyl cyclase-mediated glutamatergic synaptic plasticity in the periaqueductal grey in a rat model of neuropathic pain.

Authors:  Yu-Cheng Ho; Jen-Kun Cheng; Lih-Chu Chiou
Journal:  J Physiol       Date:  2015-05-14       Impact factor: 5.182

Review 2.  Astroglia in the Vulnerability to and Maintenance of Stress-Mediated Neuropathology and Depression.

Authors:  José Javier Miguel-Hidalgo
Journal:  Front Cell Neurosci       Date:  2022-04-22       Impact factor: 6.147

3.  Periaqueductal Gray Glutamatergic Transmission Governs Chronic Stress-Induced Depression.

Authors:  Yu-Cheng Ho; Tzer-Bin Lin; Ming-Chun Hsieh; Cheng-Yuan Lai; Dylan Chou; Yat-Pang Chau; Gin-Den Chen; Hsien-Yu Peng
Journal:  Neuropsychopharmacology       Date:  2017-08-30       Impact factor: 7.853

4.  Involvement of glutamatergic neurotransmission in the antidepressant-like effect of zinc in the chronic unpredictable stress model of depression.

Authors:  Luana M Manosso; Morgana Moretti; André R Colla; Camille M Ribeiro; Tharine Dal-Cim; Carla I Tasca; Ana Lúcia S Rodrigues
Journal:  J Neural Transm (Vienna)       Date:  2016-01-08       Impact factor: 3.575

5.  Cocaine Self-Administration and Extinction Leads to Reduced Glial Fibrillary Acidic Protein Expression and Morphometric Features of Astrocytes in the Nucleus Accumbens Core.

Authors:  Michael D Scofield; Hao Li; Benjamin M Siemsen; Kati L Healey; Phuong K Tran; Nicholas Woronoff; Heather A Boger; Peter W Kalivas; Kathryn J Reissner
Journal:  Biol Psychiatry       Date:  2015-12-31       Impact factor: 13.382

Review 6.  From pathophysiology to novel antidepressant drugs: glial contributions to the pathology and treatment of mood disorders.

Authors:  Gerard Sanacora; Mounira Banasr
Journal:  Biol Psychiatry       Date:  2013-06-15       Impact factor: 13.382

7.  Endoplasmic Reticulum Stress PERK-ATF4-CHOP Pathway Is Associated with Hypothalamic Neuronal Injury in Different Durations of Stress in Rats.

Authors:  Shanyong Yi; Weibo Shi; He Wang; Chunling Ma; Xiaojing Zhang; Songjun Wang; Bin Cong; Yingmin Li
Journal:  Front Neurosci       Date:  2017-03-24       Impact factor: 4.677

Review 8.  Astroglial correlates of neuropsychiatric disease: From astrocytopathy to astrogliosis.

Authors:  Ronald Kim; Kati L Healey; Marian T Sepulveda-Orengo; Kathryn J Reissner
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2017-10-06       Impact factor: 5.067

Review 9.  High Times for Painful Blues: The Endocannabinoid System in Pain-Depression Comorbidity.

Authors:  Marie Fitzgibbon; David P Finn; Michelle Roche
Journal:  Int J Neuropsychopharmacol       Date:  2015-09-05       Impact factor: 5.176

10.  Restraint Stress-Induced Morphological Changes at the Blood-Brain Barrier in Adult Rats.

Authors:  Petra Sántha; Szilvia Veszelka; Zsófia Hoyk; Mária Mészáros; Fruzsina R Walter; Andrea E Tóth; Lóránd Kiss; András Kincses; Zita Oláh; György Seprényi; Gábor Rákhely; András Dér; Magdolna Pákáski; János Kálmán; Ágnes Kittel; Mária A Deli
Journal:  Front Mol Neurosci       Date:  2016-01-14       Impact factor: 5.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.